L. Maitrot-mantelet, S. Leman-detours, C. De-vulpian, L. , and G. A. Ménopause, EMC -Traité Médecine AKOS, vol.7, pp.1-8, 2012.

S. Mitchell, E. , F. Woods, and N. , Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives, The American Journal of Medicine, vol.118, issue.12B, pp.14-24, 2005.

P. Naudin-rousselle and A. Gompel, La prise en charge de la périménopause, Gen FMC, pp.23-28, 2012.

C. Sonigo, G. Dray, and N. Chabbert-buffet, Le traitement hormonal de la ménopause : aspects pratiques, J Gynecol Obstet Biol Reprod (Paris), issue.41, pp.3-12, 2012.

, Réévaluation des traitements hormonaux de la ménopause, Commision Transparence Rapp Dévaluation. 28 mai, 2014.

L. Gynécologues, Ménopause AFEM, 2010.

S. O. Skouby, F. Al-azzawi, D. Barlow, J. Calaf-alsina-erdogan-ertüngealp, A. Gompel et al., Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri-and postmenopausal hormone replacement therapy, Maturitas. 16 mai, vol.51, issue.1, p.14, 2005.

V. Ringa, Les alternatives au traitement hormonal substitutif de la ménopause : le point épidémiologique, J Gynécologie Obstétrique Biol Reprod. mai, vol.33, issue.3, pp.195-209, 2004.

J. Woyka, Alternatives to hormone replacement therapy (HRT), Post Reprod Health. avr, vol.22, issue.2, p.9, 2004.

M. Rees, Alternative treatments for the menopause, Best Pract Res Clin Obstet Gynaecol. févr, vol.23, issue.1, p.61, 2009.

J. S. Carpenter and J. G. Neal, Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology, and homeopathy, Am J Med. déc, vol.118, issue.12, p.17, 2005.

J. Elis, Étude descriptive sur la prise en charge des bouffées de chaleur : enquête auprès de 108 femmes ménopausées, 2011.

H. Paquentin, Les freins à la prise en charge de la ménopause en Médecine Générale. Etude qualitative auprès des médecins généralistes du Nord-Pas-de-Calais en, 2013.

H. Faculté-de-médecine and . Warembourg, , 2014.

S. Noirault-fleury, Traitement hormonal de la ménopause (THM): Le point chez les médecins généralistes des, 2014.

J. Sousa and D. , La prise en charge de la ménopause en médecine générale en Limousin

S. C. , Université de Limoges, 2014.

P. Nalet, Le traitement hormonal de la menopause (THM) chez les jeunes medecins generalistes de Gironde : connaissances, attitudes et pratiques
URL : https://hal.archives-ouvertes.fr/dumas-01142715

S. Sherman and P. , Defining the menopausal transition, The American Journal of Medicine, vol.118, issue.12B, pp.3-7, 2005.

G. Robin and D. Dewailly, La périménopause en 2007 : de la physiopathologie à la prise en charge thérapeutique. Serv Gynécologie Endocrinienne Médecine Reprod -Hôp Jeanne Flandre -CHRU Lille, vol.9, pp.114-137, 2007.

. Ménopause and .. J. Sfe;-120apr,

S. O'neill and J. Eden, The pathophysiology of menopausal symptoms, Obstettrics Gynaecol Reprod Med, 2011.

N. Santoro and M. D. , The menopausal transition, The American Journal of Medicine, vol.118, issue.12B, pp.8-13, 2005.

, Fiche d'information aux patientes, éditée par le GEMVI. Groupe d'étude sur la ménopause et le viellissement hormonal, 2017.

R. Freedman and R. Robert, Menopausal hot flashes: Mechanisms, endocrinology, treatment, J Steroid Biochem Mol Biol. 1 juill, vol.142, 2014.

, National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms, Ann Intern Med. 21 juin, vol.142, issue.12, pp.1003-1016, 2005.

L. Dennerstein, E. C. Dudley, J. L. Hopper, J. R. Guthrie, and H. G. Burger, A Prospective PopulationBased Study of Menopausal Symptoms, vol.96, p.8, 2000.

S. M. Mckinlay, D. J. Brambilla, and J. G. Posner, The normal menopause transition. Maturitas, vol.61, p.16, 2008.

S. M. Mckinlay, D. J. Brambilla, and J. G. Posner, The normal menopause transition, 1992.

B. Letombe, Le syndrome climatérique et la qualité de vie : balance bénéfices/risques du THM et des traitements symptomatiques, 2010.

C. Jamin, La périménaupose : prise en charge thérapeutique, JTA, 2000.

V. Stearns, L. Ullmer, F. Juan, Y. Lo?pez, C. Smith et al., Hot flush. THELANCET ?, vol.360, 2002.

A. Oldenhave, L. J. Jaszmann, A. A. Haspels, and W. T. Everaerd, Impact of climacteric on wellbeing. A survey based on 5213 women 39 to 60 years old, Am J Obstet Gynecol. mars, vol.168, issue.3, p.80, 1993.

S. Palacios, Managing urogenital atrophy, Maturitas. 20 août, vol.63, issue.4, pp.315-323, 2009.

J. J. Crappier, Ménopause : conseils aux femmes et stratégie de prévention. unaformac FMC ménopause, 2002.

P. Mares, Les signes de la périménopause, Les JTA, 1996.

S. Palacios, V. W. Henderson, N. Siseles, D. Tan, and P. Villaseca, Age of menopause and impact of climacteric symptoms by geographical region. Climacteric, vol.13, pp.419-447, 2010.

S. M. Mckinlay, The normal menopause transition: an overview, Maturitas. mars, vol.23, issue.2, p.45, 1996.

A. Oldenhave, L. J. Jaszmann, A. A. Haspels, and W. T. Everaerd, Impact of climacteric on wellbeing. A survey based on 5213 women 39 to 60 years old, Am J Obstet Gynecol. mars, vol.168, issue.3, p.80, 1993.

E. B. Gold, Relation of Demographic and Lifestyle Factors to Symptoms in a MultiRacial/Ethnic Population of Women 40-55 Years of Age, Am J Epidemiol. 1 sept, vol.152, issue.5, pp.463-73, 2000.

E. W. Freeman and K. Sherif, Prevalence of hot flushes and night sweats around the world: a systematic review, Climacteric. janv, 2007.

C. M. Obermeyer, Menopause across cultures: a review of the evidence, Menopause N Y N. juin, vol.7, issue.3, p.92, 2000.

E. B. Gold, A. Colvin, A. N. Bromberger, J. Greendale, G. A. Powell et al., Longitudinal Analysis of the Association Between Vasomotor Symptoms and Race/Ethnicity Across the Menopausal Transition: Study of Women's Health Across the Nation, Am J Public Health, 2006.

M. K. Melby, D. Anderson, L. L. Sievert, and C. M. Obermeyer, Methods used in cross-cultural comparisons of vasomotor symptoms and their determinants. Maturitas, vol.70, pp.110-119, 2011.

, Population totale par sexe et âge au 1er janvier 2018, France ? Bilan démographique, Insee. INSEE. juin, 2017.

. Sfmg, Données en consultation : BOUFFE DE CHALEUR. % d'activité par tranche d'âge. Observatoire de la Médecine Générale, 2009.

S. Sherman, Introduction : menopause transition disorders, The American Journal of Medicine. The American Journal of Medicine, vol.118, issue.12B, 2005.

, Intérêt des dosages hormonaux de FSH et LH chez les femmes à partir de 45 ans, HAS, 2005.

R. Varma, D. Sinha, and J. K. Gupta, Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)-a systematic enquiry and overview, Eur J Obstet Gynecol Reprod Biol. 1 mars, vol.125, issue.1, pp.9-28, 2006.

K. Wyatt, Premenstrual syndrome, Clin Evid. juin, issue.9, pp.2125-2169, 2003.

V. Echallier and F. Le-syndrome-génito-urinaire.-généraliste, , 2017.

J. A. Suckling, R. Kennedy, A. Lethaby, and H. Roberts, Local oestrogen for vaginal atrophy in postmenopausal women, Cochrane Database of Systematic Reviews, 2006.

E. Mcauley, S. E. Doerksen, K. S. Morris, R. W. Motl, L. Hu et al., Pathways from Physical Activity to Quality of Life in Older Women, Ann Behav Med Publ Soc Behav Med. août, vol.36, issue.1, 2008.

, Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society, Menopause J North Am Menopause Soc. nov, vol.22, issue.11, pp.1155-74, 2015.

A. Daley, H. Stokes-lampard, A. Thomas, and C. Macarthur, Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev, p.6108, 2014.

C. Sonigo, G. Dray, and N. Chabbert-buffet, Le traitement hormonal de la ménopause : aspects pratiques, vol.29, 2012.

D. L. Barton, C. L. Loprinzi, S. K. Quella, J. A. Sloan, M. H. Veeder et al., Prospective evaluation of vitamin E for hot flashes in breast cancer survivors, J Clin Oncol Off J Am Soc Clin Oncol. févr, vol.16, issue.2, p.500, 1998.

, Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society, 2015.

N. Chabbert-buffet and G. Boutet, Les traitements non estrogéniques des symptômes de la ménopause : quels risques? Revues générales : Ménopause, 2012.

, The 2017 hormone therapy position statement of The North American Menopause Society: Menopause, 2017.

H. H. Berendsen, The role of serotonin in hot flushes, Maturitas, vol.36, issue.3, pp.155-64, 2000.

M. P. Freeman, R. Hill, and B. H. Brumbach, Escitalopram for perimenopausal depression: an open-label pilot study, J Womens Health, vol.15, issue.7, p.61, 2002.

C. A. Stuenkel, S. R. Davis, A. Gompel, M. A. Lumsden, M. H. Murad et al., Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, vol.100, issue.11, pp.3975-4011, 2015.

T. Guttuso, K. Kieburtz, M. Mcdermott, and . Kurlan, Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial, Obstet Gynecol. févr, vol.101, issue.2, p.45, 2003.

Y. Nir, M. I. Huang, R. Schnyer, B. Chen, and R. Manber, Acupuncture for postmenopausal hot flashes, Maturitas. avr, 2007.

T. Chien, C. Hsu, C. Liu, and C. Fang, Effect of acupuncture on hot flush and menopause symptoms in breast cancer-A systematic review and meta-analysis, PLoS ONE, vol.22, issue.2017

A. Imai, K. Matsunami, H. Takagi, and S. Ichigo, New generation nonhormonal management for hot flashes, Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. janv, vol.29, issue.1, pp.63-69, 2013.

, Conseil national de l'Ordre des Médecin. Cartographie Interactive de la Démographie Médicale, 2016.

, Groupe d'étude sur la ménopause et le viellissement hormonal. La périménopause, fiche d'information

M. Notelovitz, J. P. Lenihan, M. Mcdermott, I. J. Kerber, N. Nanavati et al., Initial 17beta-estradiol dose for treating vasomotor symptoms, Obstet Gynecol. mai, vol.95, issue.5, p.31, 2000.

J. C. Stevenson, G. Durand, E. Kahler, and T. Perty?ski, Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17?-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study. Maturitas, vol.67, pp.227-259, 2010.

D. Elia, A. Tamborini, Y. Leocmach, and H. Chadha-boreham, Efficacy and tolerability of a lowdose of Oesclim (25 mcg daily) in the management of symptomatic menopausal women: a French open-label study, Curr Med Res Opin, vol.16, issue.2, pp.94-106, 2000.

, Informations générales sur le traitement hormonal substitutif de la ménopause. afssaps, 2006.

R. Ponzone, N. Biglia, M. E. Jacomuzzi, F. Maggiorotto, L. Mariani et al., Vaginal oestrogen therapy after breast cancer: is it safe?, Eur J Cancer Oxf Engl, vol.41, issue.17, pp.2673-81, 1990.

J. Suckling, A. Lethaby, and R. Kennedy, Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev, p.1500, 2006.

T. Benoit, P. Leguevaque, M. Roumiguié, J. Beauval, B. Malavaud et al., OEstrogénothérapie locale en urologie et pelvi-périnéologie. Revue de littérature. urofrance, sept, vol.25, issue.11, p.35, 2015.

N. Biglia, V. E. Bounous, L. G. Sgro, D. 'alonzo, M. Pecchio et al., Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?, Clin Breast Cancer. déc, vol.15, issue.6, pp.413-433, 2015.

M. H. Burleson, M. Todd, and W. R. Trevathan, Daily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women, Menopause N Y N. févr, vol.17, issue.1, p.95, 2010.

J. L. Gordon, S. S. Girdler, S. E. Meltzer-brody, C. S. Stika, R. C. Thurston et al., Ovarian Hormone Fluctuation, Neurosteroids, and HPA Axis Dysregulation in Perimenopausal Depression: A Novel Heuristic Model, Am J Psychiatry. 13 janv, vol.172, issue.3, pp.227-263, 2015.

M. T. Webera, P. M. Makib, and M. Mcdermotta, Cognition and mood in perimenopause: A systematic review and meta-analysis, Journal of Steroid Biochemistry and Molecular Biology. Elsevier. 14 juin, 2013.

J. R. Hilditch, J. Lewis, A. Peter, B. Van-maris, A. Ross et al., A menopausespecific quality of life questionnaire: development and psychometric properties, Maturitas. juill, vol.24, issue.3, pp.161-75, 1996.

S. Béjean, C. Peyron, and R. Urbinelli, Variations in activity and practice patterns: a French study for GPs. Eur J Health Econ HEPAC Health Econ Prev Care, sept, vol.8, issue.3, pp.225-261, 2007.

J. M. Bensing, A. Van-den-brink-muinen, and D. H. De-bakker, Gender differences in practice style: a Dutch study of general practitioners, Med Care. mars, vol.31, issue.3, pp.219-248, 1993.

P. Breuil-genier and C. Goffette, La durée des séances des médecins généralistes, drees. avr, issue.481, 2006.

L. Gynecologues, T. Le, and . Afem;, , 2010.

P. Davis and B. Gribben, Rational prescribing and interpractitioner variation. A multilevel approach, Int J Technol Assess Health Care, vol.11, issue.3, p.42, 1995.

P. Davis, B. Gribben, A. Scott, and R. Lay-yee, The « supply hypothesis » and medical practice variation in primary care: testing economic and clinical models of inter-practitioner variation, Soc Sci Med, vol.50, issue.3, pp.407-425, 1982.

E. Amar and C. Pereira, Les prescriptions des médecins généralistes et leurs déterminants. drees, vol.440, 2005.

C. J. , Rationalité et irrationalité à l'origine du mésusage des médicaments, adsp. juin, vol.27, 1999.